Greenwich LifeSciences, Inc.

GLSI · Nasdaq · SIC 2834: Pharmaceutical Preparations
68
SEC Filings

Business Summary

PART I BUSINESS Overview We are a clinical-stage biopharmaceutical company focused on our Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination o...

Next Earnings

Q2 FY2026 — expected 2026-07-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGLSIdiscussed_in_filing Cybersecurity
topic_mentionGLSIdiscussed_in_filing Trusted Computing
topic_mentionGLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionGLSIdiscussed_in_filing Regulation
topic_mentionGLSIdiscussed_in_filing Healthcare & Bio
topic_mentionGLSIdiscussed_in_filing Sovereign & Government
topic_mentionGLSIdiscussed_in_filing Cybersecurity
topic_mentionGLSIdiscussed_in_filing Trusted Computing
topic_mentionGLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionGLSIdiscussed_in_filing Regulation
topic_mentionGLSIdiscussed_in_filing Healthcare & Bio
topic_mentionGLSIdiscussed_in_filing Sovereign & Government
topic_mentionGLSIdiscussed_in_filing Cybersecurity
topic_mentionGLSIdiscussed_in_filing Trusted Computing
topic_mentionGLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionGLSIdiscussed_in_filing Regulation
topic_mentionGLSIdiscussed_in_filing Healthcare & Bio
topic_mentionGLSIdiscussed_in_filing Sovereign & Government
topic_mentionGLSIdiscussed_in_filing Cybersecurity
topic_mentionGLSIdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-152024-12-310001641172-25-004819EDGAR62K words
2024-04-152023-12-310001493152-24-014625EDGAR
2023-03-312022-12-310001493152-23-010284EDGAR
2022-03-212021-12-310001493152-22-007377EDGAR
2021-03-312020-12-310001493152-21-007532EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023539EDGAR9K words
2025-08-142025-06-300001641172-25-024066EDGAR
2025-05-202025-03-310001641172-25-011731EDGAR
2024-11-142024-09-300001493152-24-045938EDGAR
2024-08-142024-06-300001493152-24-032278EDGAR
2024-05-202024-03-310001493152-24-020710EDGAR
2023-10-192023-09-300001493152-23-037702EDGAR
2023-08-212023-06-300001493152-23-029605EDGAR
2023-05-222023-03-310001493152-23-018539EDGAR
2022-11-142022-09-300001493152-22-032057EDGAR
2022-08-152022-06-300001493152-22-022956EDGAR
2022-05-202022-03-310001493152-22-014639EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-180001493152-25-028361EDGAR1K words
2025-07-240001641172-25-020843EDGAR
2024-12-190001493152-24-050777EDGAR
2024-06-170001493152-24-024035EDGAR
2024-02-200001493152-24-007223EDGAR
2024-02-140001493152-24-006664EDGAR
2023-12-150001493152-23-045048EDGAR
2023-04-130001493152-23-012053EDGAR
2023-03-130001493152-23-007316EDGAR
2022-12-090001493152-22-035047EDGAR

68 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001799788
TickerGLSI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 76b740c556db9a08d71a409aa1aa632be54cd89c2e1529289434ddb1f5f040a7
parent: 9a0d887e52525e53b6eaec1c065e96909585c9c34640ab3e4bc5c15356a7cbf4
content hash: b7420113f51cfb35ae9de7fa45ba1d950513474d26ce6ae75615c3ccafbc0f61
signed: 2026-04-13T04:45:18.717Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf